Diffusely Increased F-18 FDG Uptake in Bone Marrow in a Patient with Acute Anemia and Recent Erythropoietin Therapy

Clinical Nuclear Medicine

Volumn 28, Issue 9, 2003, Pages 771-772

  Plantade, Anne ^a   Montravers, Françoise ^a   Selle, Frédéric ^a   Izrael, Victor ^a   Talbot, Jean Noël ^a  

^a HÔPITAL TENON   (France)

Author keywords

Anemia; Bone marrow; Erythropoietin; FDG

Indexed keywords

ERYTHROPOIETIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; FOLINATE CALCIUM; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOGLOBIN; OXALIPLATIN;

ADULT; ANEMIA; ARTICLE; BONE MARROW; CANCER RECURRENCE; CASE REPORT; COLON RESECTION; HEMATURIA; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; RECTUM CARCINOMA; RECTUM HEMORRHAGE; WHOLE BODY SCINTISCANNING;

ANEMIA; BONE MARROW; ERYTHROPOIETIN; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS;

EID: 1542376903     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000082670.19100.83     Document Type: Article

References (8)

1. Rizzo JD, Lichtin AE, Woolf SH, et al. Use of epoietin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol. 2002;20:4083.
2. Ponchio L, Zambelli A, De Stefano A, et al. Transfusion requirement can be abolished by epoietin-a and autologous platelet predeposit in patients receiving high dose chemotherapy with stem cell support. Haematologica. 2000;85:219.
3. Patrick DL, Gagnon DD, Zagari MJ, et al. Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfa. Eur J Cancer. 2003;39:335.
4. Sugawara Y, Fisher SJ, Zasadny KR, et al. Preclinical and clinical studies of bone marrow uptake of fluorine-18-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy. J Clin Oncol. 1998;16:173.
5. Knopp MV, Bischoff H, Rimac A, et al. Bone marrow uptake of fluorine-18-fluorodeoxyglucose following treatment with hematopoietic growth factors: initial evaluation. Nucl Med Biol. 1996;23:845.
6. Hollinger EF, Alibazoglu H, Ali A, et al. Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging. Clin Nucl Med. 1998;23:93.
7. Gundlapalli S, Ojha B, Mountz JM. Granulocyte colony-stimulating factor: confounding F-18 FDG uptake in outpatient positron emission tomographic facilities for patients receiving ongoing treatment of lymphoma. Clin Nucl Med. 2002;27:140.
8. Mayer D, Bednarczyk EM. Interaction of colony-stimulating factors and fluorodeoxyglucose F(18) positron emission tomography. Ann Pharmacother. 2002;36:1796.